The Addition of Nimotuzumab During Concurrent Chemoradiotherapy Improved Survival Outcomes in Locally Advanced Nasopharyngeal Carcinoma Patients with Optimal Response to Induction Chemotherapy
BMC CANCER（2024）
关键词
Nasopharyngeal carcinoma,EGFR inhibitor,Nimotuzumab,Concurrent chemoradiotherapy,Response
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要